List view / Grid view
7 June 2017 | By Niamh Marriott, Junior Editor
Data has shown similarity in efficacy and safety between CT-P6 (biosimilar trastuzumab candidate) and reference trastuzumab treatment in patients...
6 June 2017 | By BBI Solutions
BBI Solutions, in partnership with Merck and Kinematic Automation, is hosting a lateral flow seminar designed to provide a practical insight into lateral flow test development...
6 June 2017 | By Niamh Marriott, Junior Editor
Regulatory submissions to the EMA and FDA for a single-tablet, two-drug regimen of dolutegravir & rilpivirine for the maintenance treatment of HIV...
6 June 2017 | By Niamh Marriott, Junior Editor
The FDA have approved Roche’s VENTANA ALK (D5F3) CDx Assay as a companion diagnostic to identify ALK-positive non-small cell lung cancer (NSCLC) patients...
6 June 2017 | By Niamh Marriott, Junior Editor
The strategic transaction, which consists of an exchange of Sanofi's animal health business & Boehringer Ingelheim's CHC business, has been closed in market
2 June 2017 | By Niamh Marriott, Junior Editor
Sara Rajeswaran has joined the Association of the British Pharmaceutical Industry as the new Executive Director of Government Affairs and Devolved Nations.
2 June 2017 | By Niamh Marriott, Junior Editor
ESMO welcomes the adoption of cancer resolution on prevention and control in the context of an integrated approach during the 70th World Health Assembly...
Sandoz announced that the EMA has accepted for regulatory review for biosimilars to AbbVie's Humira (adalimumab) and Janssen's Remicade (infliximab)...
1 June 2017 | By Niamh Marriott, Junior Editor
The EC has granted marketing authorisation for Ionis Pharmaceuticals’ Spinraza (nusinersen) for the treatment of 5q spinal muscular atrophy (SMA)...
1 June 2017 | By Niamh Marriott, Junior Editor
The European Medicines Agency (EMA) has approved Aptar Pharma’s integrated electronic nasal lockout device (e-Lockout) following a partnership with Takeda.
1 June 2017 | By Niamh Marriott, Junior Editor
Atlantic Healthcare announces the development of two separate tablet formulations of alicaforsen, for targeted delivery in the GI tract...
1 June 2017 | By Niamh Marriott, Junior Editor
Emblem has agreed to purchase land in preparation for the anticipated demand stemming from the proposed legalisation of adult recreational use in Canada...
1 June 2017 | By Niamh Marriott, Junior Editor
The European Medicines Agency (EMA) and the European Commission have published an information guide for healthcare professionals on biosimilar medicines...
31 May 2017 | By Niamh Marriott, Junior Editor
In a small, randomised Phase I/II clinical trial, researchers at UC San Diego School of Medicine say a 100-year-old drug called suramin...
31 May 2017 | By 42Gears Mobility Systems
42Gears recently worked with Alkem Laboratories, one of the biggest Indian pharmaceutical companies, to help secure on-field mobile devices from misuse and to enhance workforce productivity.
